08-123
Showing 26 - 50 of 2,874
Lewy Body Disease, Dementia, Parkinsonism Trial in Rochester (meta-iodobenzylguanidine (MIBG) (123I), 123I-MIBG scintigraphy)
Enrolling by invitation
- Lewy Body Disease
- +4 more
- meta-iodobenzylguanidine (MIBG) (123I)
- 123I-MIBG scintigraphy
-
Rochester, MinnesotaMayo Clinic in Rochester
Aug 23, 2022
Advanced Solid Tumors Trial in Shanghai (Relatlimab, Nivolumab)
Not yet recruiting
- Advanced Solid Tumors
- Relatlimab
- Nivolumab
-
Shanghai, Shanghai, ChinaLocal Institution
Aug 10, 2022
Melanoma, Head and Neck Squamous Cell Carcinoma Trial in Helsinki (TILT-123, Avelumab)
Recruiting
- Melanoma
- Head and Neck Squamous Cell Carcinoma
- TILT-123
- Avelumab
-
Helsinki, FinlandDocrates Cancer Center
Jul 12, 2022
Idiopathic Parkinson's Progression and Dopamine Transporter
Completed
- Parkinson Disease
- Ioflupane I 123
-
Lexington, KentuckyUniversity of Kentucky Department of Neurology
Nov 16, 2022
Diabetic Foot Ulcer, Non-healing Diabetic Foot Ulcer, Diabetic Foot Infection Trial (EPC Silver Wound Gel)
Not yet recruiting
- Diabetic Foot Ulcer
- +2 more
- EPC Silver Wound Gel
- (no location specified)
Jul 25, 2022
Post-extubation Distress During Successful Weaning
Not yet recruiting
- Transthoracic US
- Transthoracic Ultrasound
- (no location specified)
Sep 1, 2023
Pachyonychia Congenita Trial in New Brighton (PTX-022)
Recruiting
- Pachyonychia Congenita
-
New Brighton, MinnesotaMinnesota Clinical Study Center
Dec 1, 2022
Anticoagulant Trial (Heparin)
Not yet recruiting
- Anticoagulant
- Heparin
- (no location specified)
Mar 15, 2023
Myeloma Multiple Trial in Orange, Nashville (Descartes 08)
Recruiting
- Myeloma Multiple
- Descartes 08
-
Orange, California
- +1 more
Apr 4, 2022
Anticoagulant Trial (Heparin)
Not yet recruiting
- Anticoagulant
- Heparin
- (no location specified)
Mar 15, 2023
Nebulized Versus Intravenous Magnesium Sulfate in Treatment of
Completed
- Asthma Attack
- Magnesium sulfate
-
Banī Suwayf, EgyptFaculty of Medicine Beni-suef university
Jun 8, 2023
123 I-FP-CIT SPECT Prescriptions for Parkinsonian Syndromes
Completed
- Parkinson
-
Bobigny, FranceHôpital Avicenne
Jan 16, 2023
Acute Myeloid Leukemia, MDS Trial (SPRX002, ARC-T)
Not yet recruiting
- Acute Myeloid Leukemia
- Myelodysplastic Syndromes
- SPRX002
- ARC-T
- (no location specified)
Jul 12, 2022
Multiple Myeloma Trial in Worldwide (Selinexor, Dexamethasone)
Completed
- Multiple Myeloma
-
Birmingham, Alabama
- +60 more
Jan 24, 2023
Internet-based Intervention, Web-based Intervention, Online Intervention Trial in New York (An automated patient-reported
Completed
- Internet-based Intervention
- +4 more
- An automated patient-reported outcome data collection and adverse event surveillance tool
-
New York, New YorkRo HQ
May 31, 2023
Chemo-induced Peripheral Neuropathy Trial (thrombomodulin alfa, Placebo)
Withdrawn
- Chemotherapy-induced Peripheral Neuropathy
- thrombomodulin alfa
- Placebo
- (no location specified)
Feb 2, 2022
Postoperative Hyperalgesia Induced by Opioids
Completed
- Postoperative Hyperalgesia
-
Chongqing, Chongqing, ChinaDepartment of Anesthesiology, The Second Affiliated Hospital, Ch
Dec 27, 2022
Endogenous Lithium Clearance in Acute Kidney Injury
Recruiting
- Acute Kidney Injury Due to Sepsis
- +2 more
- Lithium clearance
-
Tromsø, Troms, NorwayUniversity Hospital of North Norway
Jul 31, 2023
Alcohol Abuse, Binge Drinking, Alcohol Use Disorder Trial in Stockholm (Internet-delivered Adolescent Community Reinforcement
Recruiting
- Alcohol Abuse
- +2 more
- Internet-delivered Adolescent Community Reinforcement Approach (I-A-CRA)
- Psychoeducation, information on use of alcohol and its effects
-
Stockholm, SwedeneStod, Maria Ungdom, Stockholm Centre for Dependency Disorders
Mar 29, 2022
Geographic Atrophy Associated With Age-Related Macular
Recruiting
- Age-Related Macular Degeneration
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jul 21, 2022
Breast Cancer Trial in Chicago (Cyclophosphamide, Methotrexate, Capecitabine)
Recruiting
- Breast Cancer
- Cyclophosphamide
- +2 more
-
Chicago, IllinoisUniversity of Illinois
Oct 18, 2023
Multiple Myeloma Trial in Bethesda, Oklahoma City, Fairfax (Descartes-08, Fludarabine, Cyclophosphamide)
Completed
- Multiple Myeloma
- Descartes-08
- +2 more
-
Bethesda, Maryland
- +2 more
Mar 10, 2022
Solid Tumor Trial in Helsinki (TILT-123)
Recruiting
- Solid Tumor
- TILT-123
-
Helsinki, Uusima, Finland
- +1 more
Dec 17, 2021
Acute Myeloid Leukemia (AML), B-cell Non-Hodgkin's Lymphoma (B-NHL), Multiple Myeloma (MM) Trial in Shanghai (Autologous CAR-T
Recruiting
- Acute Myeloid Leukemia (AML)
- +4 more
- Autologous CAR-T cells
- +2 more
-
Shanghai, Shanghai, ChinaShanghai Pudong Hospital, Fudan University Affiliated Pudong Med
Aug 22, 2022